Bcl-6 Oncoprotein Test

Bcl - 6- Oncoprotien test is performed on a sample of biopsy tissue to measure the level of Bcl - 6- Oncoprotien in the biopsy tissue. It is performed to confirm Anaplastic Large Cell Lymphoma, Hodgkin’s Lymphoma and Lymphoma and also during the treatment and after the treatment of Anaplastic Large Cell Lymphoma, Hodgkin’s Lymphoma and Lymphoma. It is also known as IHC Marker Bcl - 6- Oncoprotien Immunohistochemistry Biopsy Tissue, Bcl - 6- Oncoprotien Count Immunohistochemistry Biopsy Tissue.

No special preparation is required for Bcl - 6- Oncoprotien test. Inform your doctor if you're on any medications or have any underlying medical conditions or allergies before undergoing Bcl - 6- Oncoprotien test. Your doctor depending on your condition can give specific directions.

IHC-Pancytokeratin test is widely used to diagnose Anaplastic Large Cell Lymphoma, Hodgkin’s Lymphoma and Lymphoma. The normal result for Bcl - 6- Oncoprotien is a positive staining is seen in case of detection of Epithelial Origin Tumors for all genders and for All age groups.

Bcl - 6- Oncoprotien is performed using a surgical biopsy. A surgical biopsy is done while the patient is underneath local anaesthesia. Typically, this test is performed in a hospital setting where medications are administered to make the patient drowsy. The operating surgeon makes a one- to two-inch cut on the breast and then removes all or a part of the abnormal lump and sometimes a small quantity of normal-looking tissue, referred to as the “margin.” If the lump cannot be easily felt but can be seen on a mammogram or ultrasound, a radiologist may insert a thin wire to mark the suspicious spot prior to the surgeon performing the biopsy. Once again, a marker is usually placed internally at the biopsy site at the conclusion of the procedure. There might be slight pain for a couple of days once the procedure is completed.